| 1 |
27620505 | miR-92a-3p and MYCBP2 are involved in MS-275-induced and c-myc-mediated TRAIL-sensitivity in melanoma cells. | 2016 Nov |
1 |
| 2 |
26122536 | The overriding of TRAIL resistance by the histone deacetylase inhibitor MS-275 involves c-myc up-regulation in cutaneous, uveal, and mucosal melanoma. | 2015 Sep |
2 |
| 3 |
24946096 | Class I-specific histone deacetylase inhibitor MS-275 overrides TRAIL-resistance in melanoma cells by downregulating c-FLIP. | 2014 Aug |
4 |
| 4 |
22266862 | Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP. | 2012 Nov 1 |
1 |
| 5 |
22875006 | MS-275 sensitizes osteosarcoma cells to Fas ligand-induced cell death by increasing the localization of Fas in membrane lipid rafts. | 2012 Aug 9 |
1 |